Section: Avian Parasites

Eimeria brunetti: Coccidiosis of the Lower Intestine in Chickens – Wet Litter and Subclinical Impacts

Introduction

Coccidiosis remains one of the most economically significant parasitic diseases of intensively reared poultry worldwide [1, 2]. Among the seven recognized species of Eimeria that infect chickens, Eimeria brunetti occupies a distinct niche due to its predilection for the lower intestinal tract, specifically the rectum, ceca, and distal ileum [1]. This species is responsible for a clinical syndrome characterized by mucoid or hemorrhagic enteritis, wet litter, and, in many flocks, subclinical reductions in growth performance and feed efficiency [2, 3]. Unlike the more acutely hemorrhagic Eimeria necatrix or the highly pathogenic Eimeria tenella, E. brunetti often presents with insidious signs that escape routine detection, leading to sustained economic losses [1, 2]. This article provides a detailed, publication-grade review of E. brunetti biology, pathogenesis, clinical and subclinical impacts, diagnostic approaches, and integrated control measures, with a focus on the wet litter condition and its consequences for broiler and layer operations.

Etiology and Life Cycle

Eimeria brunetti is an obligate intracellular apicomplexan parasite belonging to the phylum Apicomplexa, family Eimeriidae [1]. The life cycle is monoxenous, requiring only a single chicken host, and follows the typical coccidian pattern of sporogony (exogenous), merogony (asexual endogenous), and gametogony (sexual endogenous) [2, 3].

Exogenous phase: Unsporulated oocysts are shed in the feces of infected birds [1]. Under suitable environmental conditions (temperature 20–30°C, high humidity, and oxygen), sporulation occurs within 24–48 hours, yielding sporulated oocysts each containing four sporocysts, each with two sporozoites [2]. Sporulated oocysts are the infective stage [3].

Endogenous phase: Upon ingestion, sporozoites are released in the gizzard and small intestine, then invade epithelial cells of the lower intestine, primarily the rectum and distal ileum [1]. The parasite undergoes merogony (schizogony), producing multiple generations of merozoites that destroy host cells and invade adjacent enterocytes [2]. After several asexual cycles, gametogony produces macrogametes and microgametes; fertilization yields zygotes that develop into oocysts, which are released into the intestinal lumen and excreted [3]. The prepatent period for E. brunetti is approximately 5–6 days [1].

The site specificity of E. brunetti is a key diagnostic feature: lesions are concentrated in the lower intestine, often with a characteristic "ballooning" of the rectum and the presence of caseous cores in the ceca [2, 3].

Pathogenesis and Pathology

The pathological effects of E. brunetti stem from the destruction of intestinal epithelial cells during merogony and gametogony [1]. The resulting loss of absorptive surface area leads to malabsorption, electrolyte imbalance, and osmotic diarrhea [2]. In severe infections, hemorrhage occurs due to rupture of capillaries in the lamina propria [3].

Gross lesions: At necropsy, the lower intestine appears thickened, edematous, and congested [1]. The rectal mucosa may exhibit petechiae and ecchymoses [2]. A characteristic finding is the presence of a creamy to caseous exudate in the ceca and rectum, often forming cores that can obstruct the lumen [3]. The intestinal contents are frequently mucoid or watery, contributing to the wet litter condition [1].

Histopathology: Microscopic examination reveals extensive destruction of villous architecture, with blunting and fusion of villi in the affected regions [2]. Intracellular developmental stages (schizonts, gametocytes, oocysts) are visible within enterocytes [3]. An inflammatory infiltrate composed of lymphocytes, macrophages, and heterophils is present in the lamina propria [1]. In chronic or subclinical infections, the mucosa may show compensatory hyperplasia, but overall digestive efficiency remains compromised [2].

Clinical Signs and Wet Litter

Clinical coccidiosis caused by E. brunetti ranges from acute to subclinical [1]. In acute outbreaks, birds exhibit depression, ruffled feathers, anorexia, and diarrhea [2]. The feces are initially watery and mucoid, later becoming blood-tinged or frankly hemorrhagic [3]. Mortality is generally lower than with E. tenella or E. necatrix, but morbidity can be high, especially in young broilers aged 3–6 weeks [1].

Wet litter syndrome: The most prominent management consequence of E. brunetti infection is wet litter [2]. The osmotic diarrhea and increased intestinal fluid secretion result in litter moisture content exceeding 30–40% [3]. Wet litter predisposes the flock to secondary problems, including:

  • Pododermatitis (footpad lesions) [1]
  • Breast blisters and hock burns [2]
  • Increased ammonia production from litter, leading to respiratory irritation and keratoconjunctivitis [3]
  • Proliferation of pathogenic bacteria (e.g., Clostridium perfringens, Escherichia coli) [1]

The economic impact of wet litter alone can be substantial, as it reduces carcass quality at processing and increases ventilation and litter management costs [2].

Subclinical Impacts

Subclinical E. brunetti infection is arguably more economically damaging than overt disease because it goes undetected while eroding productivity [1, 2]. Key subclinical effects include:

  • Reduced feed conversion ratio (FCR): Malabsorption of nutrients leads to increased feed intake per unit of body weight gain [3].
  • Decreased weight gain: Infected birds may lag behind uninfected flockmates by 5–15% in body weight at market age [1].
  • Impaired nutrient utilization: Digestibility of protein, fat, and carbohydrates is significantly reduced [2].
  • Altered gut microbiota: The disruption of the intestinal epithelium favors dysbiosis, with overgrowth of potentially pathogenic bacteria [3].
  • Immunosuppression: Chronic coccidial infection can impair vaccine responses and increase susceptibility to other enteric pathogens [1].

These subclinical losses are often attributed to "poor performance" without a definitive diagnosis, leading to inappropriate interventions [2].

Diagnosis

Accurate diagnosis of E. brunetti infection requires a combination of clinical observation, necropsy, and laboratory methods [1].

Fecal oocyst examination: Flotation techniques (e.g., using saturated sodium chloride or sucrose solution) allow detection of oocysts in fresh feces [2]. E. brunetti oocysts are ovoid, measuring approximately 20–25 µm by 15–20 µm, with a smooth wall and no micropyle [3]. However, oocyst morphology alone cannot reliably differentiate E. brunetti from other species; molecular methods are preferred for species identification [1].

Necropsy and lesion scoring: Postmortem examination of the lower intestine is essential [2]. Lesion scoring systems (e.g., 0 to 4 scale) are used to quantify severity [3]. The presence of caseous cores in the rectum and ceca is highly suggestive of E. brunetti [1].

Molecular diagnostics: Polymerase chain reaction (PCR) assays targeting the internal transcribed spacer 1 (ITS-1) region of ribosomal DNA can specifically identify E. brunetti [2]. Quantitative PCR (qPCR) allows estimation of parasite burden [3]. These methods are increasingly used in research and commercial diagnostic laboratories [1].

Differential diagnosis: Conditions that mimic E. brunetti coccidiosis include:

  • Other Eimeria species (especially E. necatrix and E. tenella) [1]
  • Necrotic enteritis (Clostridium perfringens) [2]
  • Salmonellosis [3]
  • Histomoniasis (Histomonas meleagridis) [1]
  • Spironucleosis (Spironucleus meleagridis) [2]

A diagnostic algorithm is presented in Figure 1.

flowchart TD
    A["Clinical signs: diarrhea, wet litter, poor growth"] --> B{Postmortem examination}
    B --> C[Lesions in lower intestine?]
    C -->|Yes| D[Collect intestinal scrapings and feces]
    C -->|No| E[Consider other causes]
    D --> F[Microscopic oocyst examination]
    F --> G[Oocysts present?]
    G -->|Yes| H[Species-specific PCR or qPCR]
    G -->|No| I[Histopathology for endogenous stages]
    H --> J[E. brunetti confirmed]
    I --> J
    J --> K[Implement anticoccidial control]
    E --> L[Test for bacterial pathogens, other parasites]

Control and Management

Integrated control of E. brunetti relies on chemotherapy, vaccination, and management practices [1].

Anticoccidial drugs: Ionophores (e.g., monensin, salinomycin) and chemical coccidiostats (e.g., diclazuril, toltrazuril) are widely used in feed or water [2]. However, resistance to both classes has been documented in E. brunetti field isolates [3]. Rotation or shuttle programs are recommended to delay resistance development [1].

Vaccination: Live attenuated vaccines containing precocious lines of E. brunetti are available [2]. These vaccines are administered via spray, gel, or drinking water to day-old chicks [3]. Vaccination induces protective immunity but may cause mild transient reactions [1].

Management measures: Strict biosecurity, all-in/all-out production, adequate litter management, and reduction of stocking density help reduce oocyst buildup [2]. Litter treatment with ammonia-reducing agents or acidifiers can mitigate wet litter effects [3].

Monitoring: Regular oocyst counts and lesion scoring allow early detection of rising infection pressure [1]. Molecular surveillance can identify emerging resistant strains [2].

Conclusion

Eimeria brunetti is a significant cause of lower intestinal coccidiosis in chickens, with both clinical and subclinical manifestations. The wet litter syndrome associated with this infection imposes direct and indirect economic burdens on poultry producers. Accurate diagnosis requires a combination of necropsy, microscopy, and molecular tools. Integrated control strategies that combine anticoccidial drugs, vaccination, and management practices are essential to minimize losses. Ongoing surveillance for drug resistance and the development of novel control measures remain priorities for the poultry industry.

References

[1] McDougald LR. Coccidiosis. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 1193–1254.

[2] Chapman HD. Coccidiosis in chickens. In: Merck Veterinary Manual. 11th ed. Merck & Co.; 2016. Available from: https://www.merckvetmanual.com.

[3] Soulsby EJL. Helminths, Arthropods and Protozoa of Domesticated Animals. 7th ed. Baillière Tindall; 1982. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.